Bryan Iorgulescu, MD, MPH, FCAP

MD Anderson Cancer Center
Houston, Texas

Bryan Iorgulescu

J. Bryan Iorgulescu, MD, MPH is a Molecular Genetic Pathology Fellow at MD Anderson Cancer Center. He completed Anatomic Pathology residency with board certification at Brigham and Women’s Hospital and postdoctoral training in cancer immunogenomics at Dana-Farber Cancer Institute/Broad Institute. Following residency, he was an Instructor in Pathology at BWH/Harvard Medical School. Dr. Iorgulescu’s efforts are dedicated to clinical NGS-based cancer testing; and to innovating molecular and spatial biomarker assays that support the evolving needs of our oncologist colleagues and clinical trial research. His research includes: (1) Dissecting the tumor microenvironment using spatial and single-cell technologies, including co-developing Slide-TCR-seq; (2) Pioneering the use of national databases to investigate the clinical utility of – and access barriers facing – molecular testing for cancer patients in the U.S.; together leading to authorship of ≥60 peer-reviewed original manuscripts (e.g. Nature, Immunity, JAMA Oncology).